A L Komarov - JoVE Visualize

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Terapevticheskii Arkhiv|October 26, 2022

[Patent foramen ovale as the cause of recurrent embolic strokes. Case report]A L Komarov, E N Krivosheeva, M I Makeev, et al.

Kardiologiia|June 2, 2011

[Factors determining clinical effectiveness of clopidogrel and prognosis of patients with stable ischemic heart disease]A L Komarov, E P Panchenko, A E Donnikov, et al.

Terapevticheskii Arkhiv|December 21, 2020

[Upper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy "REGATТA" results)]O O Shakhmatova, A L Komarov, V V Korobkova, et al.

Terapevticheskii Arkhiv|June 2, 2000

[Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension]A V Semenov, M Ia Kogan-Ponomarev, M Ia Ruda, et al.

Biomeditsinskaia Khimiia|August 25, 2022

[Coagulation activity of circulating membrane microparticles in patients with cardiovascular diseases]O A Antonova, N V Golubeva, V V Yakushkin, et al.

Terapevticheskii Arkhiv|December 30, 2023

[Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease]O O Shakhmatova, A L Komarov, E N Krivosheeva, et al.

Kardiologiia|March 18, 2021

Clinical Characteristics and Factors Associated with Poor Outcomes in Hospitalized Patients with Novel Coronavirus Infection COVID-19S A Boytsov, N V Pogosova, F N Paleev, et al.

Terapevticheskii Arkhiv|August 6, 2024

[GDF-15 and the risk of bleeding in patients with stable CAD receiving multicomponent antithrombotic therapy: the results of the prospective REGATA register]E N Krivosheeva, A L Komarov, E P Panchenko, et al.

Terapevticheskii Arkhiv|May 6, 2025

[Expert consensus on approaches to risk stratification and choice of therapy in patients with inoperable and residual chronic thromboembolic pulmonary hypertension]I E Chazova, T V Martynyuk, S N Avdeev, et al.

Kardiologiia|July 29, 2020

[Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association]Ye V Shlyakhto, G P Arutyunov, Yu N Belenkov, et al.

Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Terapevticheskii Arkhiv|October 26, 2022

[Patent foramen ovale as the cause of recurrent embolic strokes. Case report]A L Komarov, E N Krivosheeva, M I Makeev, et al.

Kardiologiia|June 2, 2011

[Factors determining clinical effectiveness of clopidogrel and prognosis of patients with stable ischemic heart disease]A L Komarov, E P Panchenko, A E Donnikov, et al.

Terapevticheskii Arkhiv|December 21, 2020

[Upper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy "REGATТA" results)]O O Shakhmatova, A L Komarov, V V Korobkova, et al.

Terapevticheskii Arkhiv|June 2, 2000

[Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension]A V Semenov, M Ia Kogan-Ponomarev, M Ia Ruda, et al.

Biomeditsinskaia Khimiia|August 25, 2022

[Coagulation activity of circulating membrane microparticles in patients with cardiovascular diseases]O A Antonova, N V Golubeva, V V Yakushkin, et al.

Terapevticheskii Arkhiv|December 30, 2023

[Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease]O O Shakhmatova, A L Komarov, E N Krivosheeva, et al.

Kardiologiia|March 18, 2021

Clinical Characteristics and Factors Associated with Poor Outcomes in Hospitalized Patients with Novel Coronavirus Infection COVID-19S A Boytsov, N V Pogosova, F N Paleev, et al.

Terapevticheskii Arkhiv|August 6, 2024

[GDF-15 and the risk of bleeding in patients with stable CAD receiving multicomponent antithrombotic therapy: the results of the prospective REGATA register]E N Krivosheeva, A L Komarov, E P Panchenko, et al.

Terapevticheskii Arkhiv|May 6, 2025

[Expert consensus on approaches to risk stratification and choice of therapy in patients with inoperable and residual chronic thromboembolic pulmonary hypertension]I E Chazova, T V Martynyuk, S N Avdeev, et al.

Kardiologiia|July 29, 2020

[Use of Statins, Anticoagulants, Antiaggregants and Antiarrhythmic Drugs in Patients With COVID-19. The Agreed Experts' Position of Russian Society of Cardiology, Eurasian Association of Therapists, National Society on Atherothrombosis, Societies of Experts in Urgent Cardiology, Eurasian Arrhythmology Association]Ye V Shlyakhto, G P Arutyunov, Yu N Belenkov, et al.

Pageof 2